The Accelerated Approval Debate: Faster FDA Drug Approvals May Mean Less Efficacy Data

Ähnliche Einträge

• Congress Is Likely to Approve Generic Drug User Fees: Action Should Spur Faster FDA Approvals
  von: Barlas, Stephen
  Veröffentlicht: (2012)
• Is the FDA approving drugs too fast? : Probably not—but drug recalls have sparked debate 
  von: Kleinke, J D, et al.
  Veröffentlicht: (1998)
• Data Sets Representative of the Structures and Experimental Properties of FDA-Approved Drugs
  von: Douguet, Dominique
  Veröffentlicht: (2018)
• Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste
  von: Gordy, James T., et al.
  Veröffentlicht: (2020)
• FDA Guidance and New Drug Approvals
  von: Walker, Scot
  Veröffentlicht: (2018)